ARTHROFISH FOR JOINTS

ARTHROFISH - a natural marine chondroprotector for joint health. This is a unique development of Russian scientists for joint health based on glucosamine, chondroitin and collagen.

Usage:

• 14 days for pain relief;
• 1 month of admission for a lasting effect;
• improving joint mobility, slowing down the destruction of cartilage;
• restorative effect with increased loads on the musculoskeletal system;
• can be used in the presence of ulcerative and inflammatory processes in the gastrointestinal tract.

100% natural preparation based on fermentalisates from the cartilage tissue of marine organisms (shark, stingray, squid, salmon), the anti-inflammatory activity of which is 50-100 times higher than that of similar substances from cattle or synthesized artificially.

Contains natural components of connective tissue, which are the building blocks of the cartilage tissue of the joints.

Advantages of the marine chondroprotector:

• beneficial effect on the joint and cartilage, which reduces the use of non-steroidal anti-inflammatory drugs (NSAIDs);
• course reception helps to slow down the progression of degenerative processes in the joints, spine and paravertebral soft tissues;
• support of the joint capsule and cartilaginous surfaces of the joints;
• significantly improves the functional state of the joints: the volume of active and passive movements increases.

The advantages of using chondroprotectors in clinical practice are a decrease in the severity of symptoms of arthrosis (pain relief, improvement of joint function), the ability to combine their use with analgesics and non-steroidal anti-inflammatory drugs, preservation of the effect after the end of treatment, the absence of serious side effects, slowing down the progression of the disease.

It was found that the cartilage tissue of marine organisms and the products of its hydrolysis exhibit anticollagenolytic (in relation to fibrillar, insoluble protein) and anticaseinolytic activity (in relation to soluble denatured protein).

Wastes from the processing of sharks, rays and sturgeons, which have a high content of "pure" non-mineralized cartilaginous tissue, as well as bone-cartilaginous waste from salmon and cod fish, are recognized as promising raw materials for obtaining biological products.

On the basis of the Primorsky Regional Center for the Prevention of Osteoarthritis, a clinical trial of the Artrofish complex from the cartilaginous tissue of aquatic organisms was carried out. At the same time, the usual drug treatment was carried out using non-steroidal anti-inflammatory drugs.

The clinical effect of the drug was expressed primarily in a decrease in the severity of pain. The first signs of a positive effect of Artrofish appeared after 2 weeks and reached a maximum after 1 month from the start of the administration, remaining stable throughout the observation period. Against the background of taking Artrofish, the functional state of the joints significantly improved - the volume of active and passive movements increased in comparison with the control group.

Thus, Arthrofish from the cartilage tissue of aquatic organisms, when used in the recommended doses, shows good clinical efficacy in moderate osteoarthritis and can be recommended for patients with a combination of osteoarthritis with the initial manifestations of osteoporosis. Arthrofish possesses both anti-inflammatory and chondroprotective properties, rapidly reduces pain syndrome, improves the functional capacity of joints.

Ingredients:

hydrolyzate from the cartilage tissue of salmon, squid, stingray and shark enzymatic.

Application method:

Adults take 2 capsules 2 times daily with meals for 30 days.

Form release: 

60 capsules 0,5g

Contraindications:

individual intolerance to the components, pregnancy, lactation.

Expiration date:

2 years. Store in a dry, dark place, out of reach of children, at a temperature not exceeding 25 ° C.

Dietary supplement. It is not a medicine.

Guaranteed authenticity and quality:

100% Original from PharmOcean Lab (Russian Federation)

Development and production:

PharmOcean Lab (Russian Federation)